Cited by 172Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology ResearchRetinal Development and Disorders

NMDA Receptor Regulation Prevents Regression of Visual Cortical Function in the Absence of Mecp2

Open access
Durand, Severine, Patrizi, Annarita, Quast, Kathleen B., Hachigian, Lea, Pavlyuk, Roman, Saxena, Alka, Carninci, Piero, Hensch, Takao K. +1 more·2012·Neuron

Abstract

SUMMARY Brain function is shaped by postnatal experience and vulnerable to disruption of Methyl-CpG-binding protein, Mecp2, in multiple neurodevelopmental disorders. How Mecp2 contributes to the experience-dependent refinement of specific cortical circuits and their impairment remains unknown. We analyzed vision in gene-targeted mice and observed an initial normal development in the absence of Mecp2. Visual acuity then rapidly regressed after postnatal day P35–40 and cortical circuits largely fell silent by P55-60. Enhanced inhibitory gating and an excess of parvalbumin-positive, perisomatic input preceded the loss of vision. Both cortical function and inhibitory hyperconnectivity were strikingly rescued independent of Mecp2 by early sensory deprivation or genetic deletion of the excitatory NMDA receptor subunit, NR2A. Thus, vision is a sensitive biomarker of progressive cortical dysfunction and may guide novel, circuit-based therapies for Mecp2 deficiency.

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2012.12.004

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Loss of vision is preceded by the accelerated development of Parvalbumin-expressing (PV+) fast-spiking basket cells that provide perisomatic inhibition to pyramidal cells.

    “Loss of vision is preceded by the accelerated development of Parvalbuminexpressing (PV+) fast-spiking basket cells that provide perisomatic inhibition to pyramidal cells 125-127 .”
  • Vision acuity initially develops normally in Mecp2 mutants but regresses in young adult mice.

    “In a pattern that resembles the relapse of RTT patients, vision acuity initially develops normally in Mecp2 mutants but regresses in young adult mice 125 .”
  • Inhibitory function seems to normalize in young adult mice, perhaps due to homeostatic compensations following long-term reduction of activity levels, but the early alterations in neural networks cause long-term functional deficits.

    “Inhibitory function seems to normalize in young adult mice 129 , perhaps due to homeostatic compensations following long-term reduction of activity levels 126 , but the early alterations in neural networks cause long-term functional deficits 125 .”
  • The precocious window of critical period plasticity observed in Mecp2 mutant mice can be rescued by reducing sensory inputs (dark-rearing), decreasing the activation of PV+ interneurons by pyramidal cells (NMDA receptor disruption) or reducing GABAergic neurotransmission (Gad67 reduction).

    “The precocious window of critical period plasticity observed in Mecp2 mutant mice (which reduces the influence of visual experience on the developing cortex) can be rescued by reducing sensory inputs (dark-rearing), decreasing the activation of PV+ interneurons by pyramidal cells (NMDA receptor disruption) or reducing GABAergic neurotransmission (Gad67 reduction) 125-127 .”
  • The abnormal activity of cortical circuits might be caused by the precocious development of GABAergic interneurons.

    “Recent studies suggest that the abnormal activity of cortical circuits might be caused by the precocious development of GABAergic interneurons, a hypothesis that has been primarily tested in the visual cortex.”

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 87 · Cited by 172

Authors
Durand, S., Patrizi, A., Quast, K. B., Hachigian, L., Pavlyuk, R., Saxena, A., Carninci, P., Hensch, T. K., & Fagiolini, M.
Affiliations
  • Boston Children's Hospital (US)
  • RIKEN (JP)
Corresponding author
Fagiolini, Michela
Venue
Neuron
Publisher
Elsevier BV
Published
2012-12
Volume
76
Issue
6
Pages
1078-1090
ISSN
0896-6273 (ISSN-L)
OpenAlex
W1999828796
Cited by
172
References
87
Citations by year
2026: 7 · 2025: 12 · 2024: 5 · 2023: 9 · 2022: 11 · 2021: 7 · 2020: 21 · 2019: 18 · 2018: 9 · 2017: 13 · 2016: 21 · 2015: 15 · 2014: 15 · 2013: 9
FWCI
7.52
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (DP1OD003699)
  • National Institute of Mental Health (T32MH020017)
  • National Institute of Neurological Disorders and Stroke (R21NS062277, R01NS070300)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655, P30HD-18655)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
MeCP2, NMDA receptor, NR2A, visual cortex, parvalbumin interneurons, sensory deprivation, MeCP2 deficiency, neurodevelopmental disorders
MeSH terms
Animals, Disease Models, Animal, Female, Male, Nerve Degeneration, Neurons, Parvalbumins, Vision Tests, Visual Acuity, Visual Cortex, Visual Pathways, Rett Syndrome, Receptors, N-Methyl-D-Aspartate, Mice, Knockout, Mice, Methyl-CpG-Binding Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review